Drug
Bezafibrate
Bezafibrate: highest development phase Phase 2, developed by Intercept Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Intercept Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| Bezafibrate 100 mg NCT05239468 | Phase 2 | Primary Biliary Cholangitis |
Latest
No recent events.
Follow Bezafibrate on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.